Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-13-005522
Filing Date
2013-02-08
Accepted
2013-02-08 21:18:58
Documents
1
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 4223
  Complete submission text file 0001140361-13-005522.txt   5648
Mailing Address C/O NEKTAR THERAPEUTICS 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Elam Nevan C (Reporting) CIK: 0001314773 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54495 | Film No.: 13588642

Mailing Address 305 W 50 STREET, APT 25A NEW YORK NY 10019
Business Address 305 W 50 STREET, APT 25A NEW YORK NY 10019 303-357-4644
AntriaBio, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 7389 Services-Business Services, NEC